Divalproex Sodium Capsule, Delayed Release
Product Images NDC 72603-260

Product Visual Gallery

This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Divalproex Sodium (NDC 72603-260). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Northstar Rx Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Container (Container)

Label for Divalproex Sodium Delayed-Release Capsules, USP 125 mg by NorthStar Rx LLC. The label shows the NDC 72603-260-01 and states valproic acid activity. It instructs pharmacists to dispense the medication guide separately and notes the capsule may be swallowed whole or contents used with food. Manufactured by Dr. Reddy's Laboratories Limited in India, with storage and handling information included.*

FDA Label Image

Figure1 (Figure1)

A cumulative distribution plot comparing the percentage of patients versus percentage reduction in CPS rate for Divalproex Sodium and placebo. The graph shows two lines: a solid line representing Divalproex Sodium and a dashed line for placebo. The y-axis ranges from -100% to 100% indicating reduction or worsening, with an arrow denoting improvement above and worsening below a zero-change line.*

FDA Label Image

Figure2 (Figure2)

A chart showing the percentage reduction in CPS rate on the vertical axis against the percentage of patients on the horizontal axis. It includes two curves labeled for high dose (solid line) and low dose (dashed line). Arrows indicate improvement upward and worsening downward with a horizontal line marking no change.*

FDA Label Image

Picture1 (Picture1)

Bottle of Divalproex sodium 125 mg delayed-release capsules. The bottle has a black child-resistant cap and a white label with black text showing part of the product name. The labeler is NorthStar Rx LLC. The bottle is held against a plain background.*

FDA Label Image

Picture2 (Picture2)

Divalproex sodium 125 mg delayed-release oral capsules. The image shows the capsule with legible imprint text "DY 5V," indicating the specific product and strength. The capsules are manufactured by NorthStar Rx LLC.*

FDA Label Image

Picture3 (Picture3)

Divalproex sodium 125 mg delayed-release capsule shown partially open with granules pouring out. The image focuses on the capsule dosage form of this oral prescription drug by NorthStar Rx LLC.*

FDA Label Image

Picture4 (Picture4)

An illustration showing a child taking an oral medication using a measuring spoon. The child is facing sideward, about to ingest the liquid from the spoon. This image demonstrates the act of administering oral medication to a child.*

FDA Label Image

Structure (Structure)

Chemical structure of divalproex sodium, showing the molecular arrangement including sodium ion and associated organic groups, as labeled in the structure.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.